REG1B and REG3G as potential serum biomarkers for diagnosis and severity stratification of atherosclerosis
Year: 2026
Type: article
Abstract: This study aimed to investigate the clinical significance of regenerating islet-derived (REG) proteins, specifically REG1B and REG3G, as novel circulating biomarkers for distinguishing atherosclerosis (AS) patients from healthy individuals and for severity assessment with particular emphasis on their association with lipid metabolism and lipid-driven vascular inflammation. Serum levels of REG proteins were measured by enzyme-linked immunosorbent assay (ELISA) in a clinical cohort comprising 172 AS patients and 115 healthy controls. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis and correlated with disease severity assessed by angiographic Gensini score and the number of obstructed vessels. An ApoE −/− rat model of lipid-driven atherosclerosis was employed for validation. Protein expression and circulating biomarkers were assessed by IHC, ELISA, and RT-qPCR. Transcriptomic analysis and weighted gene co-expression network analysis (WGCNA) were performed on rat aortic tissues to characterize molecular networks associated with lipid accumulation and vascular inflammation. REG1B and REG3G levels were significantly elevated in AS patients compared to controls and showed positive correlations with disease severity. REG1B demonstrated favorable diagnostic accuracy (AUC = 0.882) and remained elevated even in non-obstructive coronary atherosclerosis, outperforming conventional biomarkers such as hs-CRP, IL-8, and Hcy. In ApoE −/− rats, REG family proteins were upregulated in atherosclerotic aortas and circulation in parallel with progressive lipid deposition and plaque development. Network analysis revealed that Reg genes were embedded within a progressively activated immune-metabolic regulatory network associated with lipid accumulation, inflammatory activation, and atherogenesis. REG1B and REG3G are promising circulating biomarkers for AS, particularly in the context of lipid-driven vascular pathology. The ability of REG1B to remain elevated at the non-obstructive stage suggests potential for identifying coronary atherosclerosis in symptomatic populations. Their association with disease severity and integration within lipid-linked immune regulatory networks suggest potential roles in coordinating metabolic inflammation during atherogenesis.
Institution: Meizhou City People's Hospital
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W7233580150
FWCI:
Cites:
Cited by:
Related to:
